Rohit Mehra Selected Research

Leiomyomatosis

1/2021	New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
12/2018	Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples.
10/2018	Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma.
1/2018	The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.
1/2018	Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
7/2017	A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.
11/2016	Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma.
10/2016	Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification.
1/2016	Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
12/2015	Emerging Entities in Renal Neoplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rohit Mehra Research Topics

Disease

93	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2004
84	Neoplasms (Cancer) 11/2022 - 12/2004
26	Neoplasm Metastasis (Metastasis) 10/2021 - 02/2006
25	Renal Cell Carcinoma (Grawitz Tumor) 11/2022 - 11/2014
18	Carcinoma (Carcinomatosis) 01/2022 - 06/2005
10	Leiomyomatosis 01/2021 - 12/2015
9	Adenocarcinoma 01/2020 - 05/2006
6	Urinary Bladder Neoplasms (Bladder Cancer) 06/2022 - 05/2009
5	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 11/2014
4	Prostatic Intraepithelial Neoplasia 01/2021 - 02/2008
4	Margins of Excision 01/2020 - 10/2006
4	Disease Progression 01/2018 - 05/2007
4	Carcinogenesis 01/2018 - 08/2013
4	Breast Neoplasms (Breast Cancer) 11/2011 - 06/2005
3	Teratoma (Teratoid Tumor) 12/2018 - 07/2017
3	Fibrosis (Cirrhosis) 11/2016 - 01/2012
2	Melanoma (Melanoma, Malignant) 10/2021 - 08/2013
2	Kidney Neoplasms (Kidney Cancer) 01/2021 - 01/2019
2	Angiomyolipoma 07/2019 - 11/2014
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 05/2019 - 01/2018
2	Embryonal Carcinoma 12/2018 - 01/2018
2	Seminoma 12/2018 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018 - 12/2015
2	Merkel Cell Carcinoma 09/2017 - 08/2012
2	Small Cell Carcinoma 12/2015 - 08/2012
2	Extranodal Extension 12/2014 - 10/2006
1	Hypertension (High Blood Pressure) 11/2022
1	Glomus Tumor (Glomus Tumors) 11/2022
1	Peritoneal Neoplasms 01/2022
1	COVID-19 01/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021
1	Necrosis 01/2021

Drug/Important Bio-Agent (IBA)

27	AndrogensIBA 10/2021 - 12/2004
24	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2005
22	Biomarkers (Surrogate Marker)IBA 06/2022 - 06/2005
16	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2006
13	Fumarate Hydratase (Fumarase)IBA 01/2021 - 04/2014
11	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 09/2005
10	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 07/2009
8	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021 - 12/2015
7	ChromatinIBA 01/2022 - 07/2010
7	Biological ProductsIBA 12/2020 - 05/2007
6	Messenger RNA (mRNA)IBA 01/2021 - 09/2007
6	Hormones (Hormone)IBA 01/2019 - 12/2004
6	Long Noncoding RNAIBA 01/2018 - 12/2014
6	Proto-Oncogene Proteins c-etsIBA 08/2013 - 10/2005
5	Transcription Factors (Transcription Factor)IBA 01/2022 - 09/2007
5	EnzymesIBA 01/2016 - 06/2005
4	trans-sodium crocetinate (crocetin)IBA 01/2022 - 11/2014
4	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 06/2011
4	Kazal Pancreatic Trypsin InhibitorIBA 02/2016 - 02/2008
4	Complementary DNA (cDNA)IBA 06/2011 - 12/2004
3	Formaldehyde (Formol)FDA Link 12/2018 - 03/2015
3	ParaffinIBA 12/2018 - 03/2015
3	B7-H1 AntigenIBA 10/2018 - 10/2017
3	Sarcosine (Methylglycine)IBA 05/2013 - 02/2009
3	Monoclonal AntibodiesIBA 08/2012 - 12/2005
3	5' Untranslated Regions (5' UTR)IBA 08/2007 - 10/2005
2	Chemokine ReceptorsIBA 01/2022 - 02/2008
2	enzalutamideIBA 01/2022 - 01/2019
2	Keratins (Keratin)IBA 10/2021 - 05/2006
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 10/2016
2	Phenobarbital (Luminal)FDA Link 01/2021 - 12/2018
2	Microphthalmia-Associated Transcription FactorIBA 01/2021 - 01/2016
2	GP 4 (GP4)IBA 01/2021 - 10/2015
2	Hematoxylin (Haematoxylon)IBA 01/2020 - 06/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 06/2017
2	Phosphotransferases (Kinase)IBA 01/2019 - 11/2011
2	Capsules (Microcapsules)IBA 01/2018 - 06/2014
2	LigandsIBA 10/2017 - 02/2016
2	Tumor Viral Antigens (Large T Antigen)IBA 09/2017 - 09/2015
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 05/2013 - 02/2009
2	Histone MethyltransferasesIBA 01/2013 - 06/2012
2	Histones (Histone)IBA 07/2012 - 06/2012
2	Estrogen ReceptorsIBA 06/2009 - 12/2005
1	ReninIBA 11/2022
1	AngiotensinsIBA 11/2022
1	gallium 68 PSMA-11IBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Androgen Antagonists (Antiandrogens)IBA 01/2020
1	cabozantinibIBA 01/2020

Therapy/Procedure

30	Therapeutics 01/2022 - 10/2006
27	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 10/2006
19	Radiotherapy 12/2021 - 10/2006
14	Castration 01/2022 - 07/2010
4	Nephrectomy 01/2022 - 03/2015
4	Drug Therapy (Chemotherapy) 01/2021 - 02/2016
3	Precision Medicine 12/2020 - 08/2014
3	Lasers (Laser) 09/2007 - 01/2007
2	Brachytherapy 10/2020 - 01/2019
2	Orchiectomy (Orchidectomy) 05/2019 - 01/2018
2	Immunotherapy 01/2017 - 02/2016
1	Thrombectomy 01/2022
1	Contraindications 01/2020